CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 384 enrolled
Drug / intervention
Letrozole +1 moredrug
Likely dose
Letrozole 2.5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02491320
NCT02491320Phase 3Completed

Effect of Acupuncture Pre-treatment Combined With Letrozole on Live Birth in Infertile Women With Polycystic Ovary Syndrome

The First Affiliated Hospital of Guangzhou Medical University·interventional·Posted Jul 8, 2015·Updated Jun 23, 2021

In Brief

A Phase 3 clinical trial evaluating Pre-treatment acupuncture and Letrozole for Polycystic Ovary Syndrome. Completed, enrolled 384 participants across 1 site.

Detailed Summary

This is a study protocol for a multicenter, randomized, and controlled trial. In this protocol, we present a randomized controlled trial comparing acupuncture pretreatment followed by letrozole vs letrozole alone in polycystic ovary syndrome (PCOS) women with anovulatory infertility. The high prevalence of insulin resistance (IR) in women with PCOS women is considered to be one of the major pathophysiological changes of PCOS, leading to anovulatiory infertility. A study has shown that electro-acupuncture could significantly improve insulin sensitivity. The effect of acupuncture pretreatment on anovulatory PCOS women followed by ovulation induction has not been investigated before. A total of 384 patients enrolled in this study will be randomized into one of two groups. The treatment group: a 16 week acupuncture pretreatment followed by 4 cycles of letrozole and the control group: 4 cycles of letrozole alone. The primary outcome is the live birth rate. We postulate that acupuncture pretreatment followed by letrozole results in a higher live birth rate when compared with letrozole alone.

Study Details

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 8, 2015
Enrollment StartAug 1, 2015
Primary CompletionOct 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 11.0 years ago

Interventions

Pre-treatment acupunctureother

Acupuncture treatment will start on day 3-5 after a spontaneous period or after a withdrawal bleeding following progestin. They will receive acupuncture treatment three times a week. Each treatment session lasts for 30 minutes and can be separated by an interval of 1-3 days, with a maximum of 48 treatment sessions during 16 weeks.

Letrozoledrug

Starting from 2.5mg daily from day 3-5 for 5 days after a spontaneous period or after a withdrawal bleeding following progestin, one time per day.Participants are treated for up to 4 cycles.